Legal & General Group PLC Gossamer Bio, Inc. Transaction History

Legal & General Group PLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $12,590 - $38,295	-13,115 Reduced 63.77%	7,451 $9,000
Q4 2022 Feb 14, 2023	SELL	$1.74 - $12.87 $713 - $5,276	-410 Reduced 1.95%	20,566 $44,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $22,170 - $45,756	3,075 Added 17.18%	20,976 $251,000
Q2 2022 Aug 22, 2022	SELL	$5.97 - $9.97 $752 - $1,256	-126 Reduced 0.7%	17,901 $150,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $4,000 - $5,920	474 Added 2.7%	18,027 $156,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $2,884 - $4,009	-285 Reduced 1.6%	17,553 $199,000
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $72,478 - $132,260	9,997 Added 127.5%	17,838 $225,000
Q2 2021 Aug 12, 2021	SELL	$8.0 - $9.75 $4,992 - $6,084	-624 Reduced 7.37%	7,841 $63,000
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $1,829 - $2,319	-212 Reduced 2.44%	8,465 $79,000
Q3 2020 Nov 13, 2020	SELL	$11.3 - $14.75 $16,317 - $21,299	-1,444 Reduced 14.27%	8,677 $107,000
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $28,502 - $47,844	2,994 Added 42.01%	10,121 $132,000
Q1 2020 May 14, 2020	SELL	$8.0 - $15.48 $15,616 - $30,216	-1,952 Reduced 21.5%	7,127 $72,000
Q4 2019 Feb 13, 2020	BUY	$14.82 - $26.79 $14,167 - $25,611	956 Added 11.77%	9,079 $141,000
Q3 2019 Nov 13, 2019	BUY	$16.02 - $22.47 $60,859 - $85,363	3,799 Added 87.86%	8,123 $137,000
Q2 2019 Aug 14, 2019	BUY	$16.12 - $22.89 $41,541 - $58,987	2,577 Added 147.51%	4,324 $96,000
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $30,712 - $41,875	1,747 New	1,747 $38,000

115

163M

821K

557K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $76.1M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.